BioCryst Pharmaceuticals | BCRX - EPS Earnings Per Share


BioCryst Pharmaceuticals reported $0.3 in EPS Earnings Per Share for its fiscal quarter ending in June of 2026.





Eps Change Date
Alnylam Pharmaceuticals USD 16.26 14.42 Sep/2026
BioCryst Pharmaceuticals USD 0.3 0.87 Jun/2026
Chugai Pharma JPY 87.23 16.54 Sep/2026
Daiichi Sankyo JPY 45.5 7.78 Sep/2026
DBV Technologies USD -0.7 0.15 Sep/2026
Enanta Pharmaceuticals USD -1.05 0.31 Dec/2024
Gilead Sciences USD 2.55 9.3 Sep/2026
GlaxoSmithKline GBP 0.55 0.04 Sep/2026
Glaxosmithkline GBP 0.76 0.14 Sep/2026
Incyte USD -3.6 6.69 Sep/2026
Ionis Pharmaceuticals USD 0.66 1.35 Sep/2026
Karyopharm Therapeutics USD -1.02 1.2 Mar/2026
Neurocrine Biosciences USD 3.29 0.44 Sep/2026
Novavax USD 0.13 0.59 Dec/2025
PTC Therapeutics USD -0.62 1.54 Sep/2026
Regeneron Pharmaceuticals USD 20.07 5.78 Sep/2026
Roche Holding CHF 10.98 2.61 Jun/2026
Sarepta Therapeutics USD 0.13 0.51 Sep/2026
Ultragenyx Pharmaceutical USD -1.16 0.26 Sep/2026
Vertex Pharmaceuticals USD 4.76 0.03 Sep/2026